Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy K Huyck

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literatureLauren Nye, Timothy K Huyck, William J Gradishar
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Chemotherapy|March 15, 2012
Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinibJana Svetlichnaya, Timothy K Huyck, Jeffrey D Wayne, et al.
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Eclinicalmedicine|April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyMarwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2012
Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literatureLauren Nye, Timothy K Huyck, William J Gradishar
Nature Reviews. Drug Discovery|March 2, 2011
Eribulin mesylateTimothy K Huyck, William Gradishar, Fil Manuguid, et al.
Chemotherapy|March 15, 2012
Neoadjuvant use of sunitinib in locally advanced GIST with intolerance to imatinibJana Svetlichnaya, Timothy K Huyck, Jeffrey D Wayne, et al.
The Oncologist|August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT studyErkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Eclinicalmedicine|April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyMarwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Pageof 1